Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
daniel o'day
deals
dow jones
fda
foundation medicine
foundationone cdx
foundationone heme
genentech
life sciences
nasdaq
national blog main
national top stories
new york blog main
news
osimertinib
politics
roche
rucaparib (rubraca)
s&p 500
san francisco blog main
u.s. market news
unitedhealth group
What
confidence
2
×
stock
2
×
acquire
agreed
bashes
big
billion
boss
broad
broader
ccn
didn’t
dow
foundation
gain
gains
gave
genentech
health
investors
market
medicare
medicine
momentum
morning
panels
pay
pays
picked
profiling
promising
questions
raised
recently
recoils
redux
remaining
rest
roche
roiled
Language
Current search:
stock
×
confidence
×
@ccn.com
5 years ago
Dow Recoils as UnitedHealth Boss Bashes Medicare for All
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
